Features

• The BD Veritor System for Rapid Detection of SARS-CoV-2 is intended for use by trained clinical laboratory personnel specifically instructed and trained in the techniques of in vitro diagnostic procedures, and proper infection control procedures and individuals similarly trained in point of care settings.
• Kit contents include 30 single-use test devices; 30 single-use reaction tubes; 30 sterile single-use specimen sampling swabs; positive SARS-CoV-2 control swab; negative SARS-CoV-2 control swab; instructions for use; quick reference card; and nasal sampling instructions.
• Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests.
• Product ships with minimum 30 days dating.
• Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
• Positive results do not rule out bacterial infection or co-infection with other viruses.